A biologist's perspective on malaria vaccine development.
about
Plasticity in parasite phenotypes: evolutionary and ecological implications for diseaseMultiple pathways for Plasmodium ookinete invasion of the mosquito midgutThe activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasitesA viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activityIdentification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium bergheiPlasmodium vivax malaria vaccines: why are we where we are?A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugsNowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAMalaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.Transmission-blocking interventions eliminate malaria from laboratory populations.Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.CRIMALDDI: platform technologies and novel anti-malarial drug targets.Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs.Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.Expression of the Plasmodium falciparum Clonally Variant clag3 Genes in Human Infections.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.Immune Responses in Malaria.Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector.Plasmodium berghei Cap93, a novel oocyst capsule-associated protein, plays a role in sporozoite development.Antimalarial drug delivery to the mosquito: an option worth exploring?Malaria vaccine: a bright prospect for elimination of malaria.Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.A high throughput screen for next-generation leads targeting malaria parasite transmission
P2860
Q26849615-92A8CD5A-F022-4B7E-9656-CBC720A10786Q27973868-ADB790A3-DE90-4AB7-A7F9-6ECF0FE9917EQ28480979-115A14AA-DEC4-42EF-AE10-D35BFA8C52E8Q28740771-06C0F0FD-4828-45ED-9142-0587C297A1B5Q30043378-6CBC474B-855A-46DE-BB33-B7B2B83CE015Q34170071-8CC9280B-CF8A-430C-874D-D65ADB4D6D9FQ34597517-5C20FD69-EAC1-425C-81C5-7A06E944E886Q35666885-F4CAC83C-2A38-4ED8-86B1-6CB19EBAC2B7Q36694820-DAE3FFDC-D7EF-4624-BD3A-CEEA4A356F83Q36795388-1B926DEE-1725-4E76-899B-8550F77BE7BAQ36906724-3AE668DD-D38E-4944-B837-442FF4C55803Q36998403-AD24E6FD-B8F2-484F-AFCD-DFAD65B3F88BQ37176727-F6411ADA-776F-444F-A206-537C9C7B06F3Q37308061-A9963661-5802-4CFE-B4C0-6869A371C0DAQ38066991-A0A99C9D-4C01-4604-8471-C6542A851BF6Q38714971-C6AB1387-813B-4E52-8053-436A5456879CQ39253313-E056562A-5224-49DF-863F-3EB36F0D9D71Q39296506-E5E680D0-90C2-4D25-AFE9-30949D6EBD9EQ39343656-7F58029E-D4EE-4536-BFF7-12AF075C1E8AQ40259888-2962756E-4603-4964-B769-AE044D27AA0EQ40331757-D1289AE5-7072-41C7-9A08-FB5A8237A156Q41541802-301DED9D-43C0-48C4-83B0-3E1FE7E142DCQ44144159-E79245A0-04F1-42FE-9736-D9A5F6181514Q46217764-0A8AE817-CC10-40D7-B8F0-52BF3830D166Q47711225-B617F971-2323-4F3F-BF2B-9A4CF1056241Q57155783-DE7D13C7-9E3A-46F7-BBD0-31DDCBEDA9A4
P2860
A biologist's perspective on malaria vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A biologist's perspective on malaria vaccine development.
@en
A biologist's perspective on malaria vaccine development.
@nl
type
label
A biologist's perspective on malaria vaccine development.
@en
A biologist's perspective on malaria vaccine development.
@nl
prefLabel
A biologist's perspective on malaria vaccine development.
@en
A biologist's perspective on malaria vaccine development.
@nl
P356
P1433
P1476
A biologist's perspective on malaria vaccine development.
@en
P2093
Robert E Sinden
P356
10.4161/HV.6.1.9604
P577
2010-01-24T00:00:00Z